Spatzenegger M - Search Results

1

CYP1A1 but not CYP1A2 proteins are expressed in human lymphocytes.

Spatzenegger M, Horsmans Y, Verbeeck RK. Spatzenegger M, et al. Pharmacol Toxicol. 2000 May;86(5):242-4. doi: 10.1034/j.1600-0773.2000.d01-42.x. Pharmacol Toxicol. 2000. PMID: 10862507 No abstract available.

2

Differential activities of CYP1A isozymes in hepatic and intestinal microsomes of control and 3-methylcholanthrene-induced rats.

Spatzenegger M, Horsmans Y, Verbeeck RK. Spatzenegger M, et al. Pharmacol Toxicol. 2000 Feb;86(2):71-7. doi: 10.1034/j.1600-0773.2000.d01-14.x. Pharmacol Toxicol. 2000. PMID: 10728918

3

Metabolism of dextromethorphan in human liver microsomes: a rapid HPCL assay to monitor cytochrome P450 2D6 activity.

Vielnascher E, Spatzenegger M, Mayrhofer A, Klinger P, Jäger W. Vielnascher E, et al. Among authors: spatzenegger m. Pharmazie. 1996 Aug;51(8):586-8. Pharmazie. 1996. PMID: 8794469

4

Determination of the new MDR-modifier PFP 6 and its metabolites in human liver microsomes by high-performance liquid chromatography.

Spatzenegger M, Ecker G, Jäger W. Spatzenegger M, et al. Biomed Chromatogr. 1996 May-Jun;10(3):127-30. doi: 10.1002/(SICI)1099-0801(199605)10:3<127::AID-BMC568>3.0.CO;2-Z. Biomed Chromatogr. 1996. PMID: 8792863

5

Clinical importance of hepatic cytochrome P450 in drug metabolism.

Spatzenegger M, Jaeger W. Spatzenegger M, et al. Drug Metab Rev. 1995;27(3):397-417. doi: 10.3109/03602539508998329. Drug Metab Rev. 1995. PMID: 8521748 Review. No abstract available.

6

Metabolism of resveratrol in breast cancer cell lines: impact of sulfotransferase 1A1 expression on cell growth inhibition.

Murias M, Miksits M, Aust S, Spatzenegger M, Thalhammer T, Szekeres T, Jaeger W. Murias M, et al. Among authors: spatzenegger m. Cancer Lett. 2008 Mar 18;261(2):172-82. doi: 10.1016/j.canlet.2007.11.008. Epub 2007 Dec 20. Cancer Lett. 2008. PMID: 18082939

7

Amino acid residues critical for differential inhibition of CYP2B4, CYP2B5, and CYP2B1 by phenylimidazoles.

Spatzenegger M, Wang Q, He YQ, Wester MR, Johnson EF, Halpert JR. Spatzenegger M, et al. Mol Pharmacol. 2001 Mar;59(3):475-84. doi: 10.1124/mol.59.3.475. Mol Pharmacol. 2001. PMID: 11179442

8

Analysis of differential substrate selectivities of CYP2B6 and CYP2E1 by site-directed mutagenesis and molecular modeling.

Spatzenegger M, Liu H, Wang Q, Debarber A, Koop DR, Halpert JR. Spatzenegger M, et al. J Pharmacol Exp Ther. 2003 Jan;304(1):477-87. doi: 10.1124/jpet.102.043323. J Pharmacol Exp Ther. 2003. PMID: 12490624

9

A truncation of 2B subfamily cytochromes P450 yields increased expression levels, increased solubility, and decreased aggregation while retaining function.

Scott EE, Spatzenegger M, Halpert JR. Scott EE, et al. Among authors: spatzenegger m. Arch Biochem Biophys. 2001 Nov 1;395(1):57-68. doi: 10.1006/abbi.2001.2574. Arch Biochem Biophys. 2001. PMID: 11673866

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Search Page

Filters